Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  MET tyrosine kinase inhibitor SAR125844
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-3 of 3 for your search:
Start Over
A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ACT14205, 2014-005696-93, U1111-1163-1136, NCT02435121
Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED11449, 2010-021398-36, U1111-1117-9878, NCT01391533
Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED12337, U1111-1126-7527, NCT01657214
Start Over